The contribution of secondary causes to low bone mass in postmenopausal women with osteoporosis is unknown. A study by Cerdá Gabaroi et al. aimed to fill this gap. While the researchers found a high prevalence of secondary causes, the importance of clinical risk factors should not be underestimated in the primary care setting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cerdá Gabaroi, D. et al. Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause 17, 135–139 (2010).
Black, D. M. et al. Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J. Bone Miner. Res. 10, 890–902 (1995).
Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007).
Tang, B. M., Eslick, G. D., Nowson, C., Smith, C. & Bensoussan, A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657–666 (2007).
Priemel, M. et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 25, 305–312 (2009).
Deutschmann, H. A. et al. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J. Intern. Med. 252, 389–397 (2002).
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M. & Rubin, M. R. Presentation of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94, 351–365 (2009).
Tannenbaum, C. et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J. Clin. Endocrinol. Metab. 87, 4431–4437 (2002).
[No authors listed] Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17, 25–54 (2010).
WHO Scientific Group Technical Report. Kanis, J. A. on behalf of the World Health Organisation Scientific Group. Assessment of osteoporosis at the primary health care level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield. Assessment of osteoporosis at the primary health care level online, (2008).
Acknowledgements
The authors' research is supported by NIH grant AG28168.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gallagher, J., Sai, A. Is screening for secondary causes of osteoporosis worthwhile?. Nat Rev Endocrinol 6, 360–362 (2010). https://doi.org/10.1038/nrendo.2010.86
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.86
This article is cited by
-
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis
Osteoporosis International (2023)
-
Recognizing and treating secondary osteoporosis
Nature Reviews Rheumatology (2012)
